WO2021186482A1 - Production plant of a dilutable liquid saline concentrate for obtaining water intended for human consumption - Google Patents
Production plant of a dilutable liquid saline concentrate for obtaining water intended for human consumption Download PDFInfo
- Publication number
- WO2021186482A1 WO2021186482A1 PCT/IT2021/000013 IT2021000013W WO2021186482A1 WO 2021186482 A1 WO2021186482 A1 WO 2021186482A1 IT 2021000013 W IT2021000013 W IT 2021000013W WO 2021186482 A1 WO2021186482 A1 WO 2021186482A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tank
- calcium
- salts
- mixing tank
- storing
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title claims abstract description 34
- 239000007788 liquid Substances 0.000 title claims abstract description 33
- 239000011780 sodium chloride Substances 0.000 title claims abstract description 30
- 239000012141 concentrate Substances 0.000 title claims abstract description 27
- 235000008504 concentrate Nutrition 0.000 title claims description 24
- 235000020354 squash Nutrition 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title description 4
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 66
- 150000003839 salts Chemical class 0.000 claims abstract description 37
- 238000002156 mixing Methods 0.000 claims abstract description 36
- 238000003860 storage Methods 0.000 claims abstract description 24
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 14
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims abstract description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- 238000010907 mechanical stirring Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 9
- 235000010216 calcium carbonate Nutrition 0.000 claims description 8
- 229960003563 calcium carbonate Drugs 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 6
- 159000000003 magnesium salts Chemical class 0.000 claims description 5
- RSYSVNVHLXTDIR-ZZMNMWMASA-L (2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate;manganese(2+) Chemical compound [Mn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] RSYSVNVHLXTDIR-ZZMNMWMASA-L 0.000 claims description 3
- MWWMZNITXBJVSP-DKWTVANSSA-L (2s)-2-aminobutanedioate;manganese(2+) Chemical compound [Mn+2].[O-]C(=O)[C@@H](N)CC([O-])=O MWWMZNITXBJVSP-DKWTVANSSA-L 0.000 claims description 3
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 3
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 claims description 3
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 claims description 3
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 3
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 3
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 3
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims description 3
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- 229940047036 calcium ascorbate Drugs 0.000 claims description 3
- 239000011692 calcium ascorbate Substances 0.000 claims description 3
- 235000010376 calcium ascorbate Nutrition 0.000 claims description 3
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 claims description 3
- 229940052299 calcium chloride dihydrate Drugs 0.000 claims description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
- 239000001354 calcium citrate Substances 0.000 claims description 3
- 229960004256 calcium citrate Drugs 0.000 claims description 3
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 3
- 229910001634 calcium fluoride Inorganic materials 0.000 claims description 3
- 229940095626 calcium fluoride Drugs 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 claims description 3
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 229940074358 magnesium ascorbate Drugs 0.000 claims description 3
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 claims description 3
- 235000002538 magnesium citrate Nutrition 0.000 claims description 3
- 239000004337 magnesium citrate Substances 0.000 claims description 3
- 229960005336 magnesium citrate Drugs 0.000 claims description 3
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 claims description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 3
- 239000000347 magnesium hydroxide Substances 0.000 claims description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 3
- 229960000816 magnesium hydroxide Drugs 0.000 claims description 3
- 235000012254 magnesium hydroxide Nutrition 0.000 claims description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 3
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 claims description 3
- 229940038584 manganese aspartate Drugs 0.000 claims description 3
- 239000011656 manganese carbonate Substances 0.000 claims description 3
- 235000006748 manganese carbonate Nutrition 0.000 claims description 3
- 229940093474 manganese carbonate Drugs 0.000 claims description 3
- 239000011565 manganese chloride Substances 0.000 claims description 3
- 235000002867 manganese chloride Nutrition 0.000 claims description 3
- 229940099607 manganese chloride Drugs 0.000 claims description 3
- 239000011564 manganese citrate Substances 0.000 claims description 3
- 235000014872 manganese citrate Nutrition 0.000 claims description 3
- 229940097206 manganese citrate Drugs 0.000 claims description 3
- 239000011683 manganese gluconate Substances 0.000 claims description 3
- 235000014012 manganese gluconate Nutrition 0.000 claims description 3
- 229940072543 manganese gluconate Drugs 0.000 claims description 3
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 claims description 3
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims description 3
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 229940068988 potassium aspartate Drugs 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 3
- 239000011698 potassium fluoride Substances 0.000 claims description 3
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- 235000013926 potassium gluconate Nutrition 0.000 claims description 3
- 239000004224 potassium gluconate Substances 0.000 claims description 3
- 229960003189 potassium gluconate Drugs 0.000 claims description 3
- 235000007715 potassium iodide Nutrition 0.000 claims description 3
- 229960002718 selenomethionine Drugs 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 229940001593 sodium carbonate Drugs 0.000 claims description 3
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- 229960002668 sodium chloride Drugs 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 239000011775 sodium fluoride Substances 0.000 claims description 3
- 235000013024 sodium fluoride Nutrition 0.000 claims description 3
- 229960000414 sodium fluoride Drugs 0.000 claims description 3
- 235000012207 sodium gluconate Nutrition 0.000 claims description 3
- 239000000176 sodium gluconate Substances 0.000 claims description 3
- 229940005574 sodium gluconate Drugs 0.000 claims description 3
- 239000011655 sodium selenate Substances 0.000 claims description 3
- 235000018716 sodium selenate Nutrition 0.000 claims description 3
- 229960001881 sodium selenate Drugs 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- OKUCEQDKBKYEJY-UHFFFAOYSA-N tert-butyl 3-(methylamino)pyrrolidine-1-carboxylate Chemical compound CNC1CCN(C(=O)OC(C)(C)C)C1 OKUCEQDKBKYEJY-UHFFFAOYSA-N 0.000 claims description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 3
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 3
- 229940056904 zinc ascorbate Drugs 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims description 3
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 claims description 3
- 230000005587 bubbling Effects 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 235000014666 liquid concentrate Nutrition 0.000 description 12
- 235000020682 bottled natural mineral water Nutrition 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 3
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- -1 Ca2+ ions Chemical class 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F9/00—Multistage treatment of water, waste water or sewage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/26—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by irradiation without heating
- A23L3/28—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by irradiation without heating with ultraviolet light
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/55—Rehydration or dissolving of foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/54—Mixing with gases
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/008—Control or steering systems not provided for elsewhere in subclass C02F
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/441—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/66—Treatment of water, waste water, or sewage by neutralisation; pH adjustment
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A20/00—Water conservation; Efficient water supply; Efficient water use
- Y02A20/124—Water desalination
- Y02A20/131—Reverse-osmosis
Definitions
- the present invention relates to a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or also one not present in nature, the liquid concentrate thus obtained and the water intended for human consumption produced with the liquid concentrate thus obtained.
- the second problem is that account must also be taken of the possible precipitation of salts precisely in the liquid concentrate, either at the moment of preparation, or over time, as a consequence of temperature variations, exposure to UV rays, etc.
- the most critical aspect regards precisely the possible precipitation of Calcium Carbonate.
- the technical task of the present invention is therefore to provide a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or one that is not present in nature, which enables the aforementioned technical drawbacks of the prior art to be eliminated.
- one object of the invention is to provide a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or one that is not present in nature, wherein the liquid concentrate produced has a reasonable calcium-carbonate balance and a negligible or zero quantity of precipitated salts, particularly of Calcium Carbonate.
- a system for producing a liquid saline concentrate that can be diluted to obtain water intended for human consumption, characterised in that it comprises a reverse osmosis demineraliser for preparing demineralised water, a sterilising means for sterilising said demineralised water, a source of CO2, a carbonator for carbonating said sterilised water, a mixing tank connected to said carbonator, a supply circuit for supplying salts to said mixing tank, an adjustment means for adjusting the pH of the liquid saline concentrate present in the mixing tank in an interval comprised between 4 and 9, a mechanical stirring means for stirring the liquid saline concentrate present in the mixing tank, said supply circuit comprising a plurality of storage tanks for storing salts in crystalline form or in liquid form connected to said demineraliser, and for each storage tank a corresponding dosing pump, said storage tanks comprising a tank for storing potassium bicarbonate salt and/or
- salts in appropriate quantities based on the recipes, selected from among calcium ascorbate, calcium carbonate, calcium sulphate dihydrate, calcium citrate, calcium fluoride, calcium chloride dihydrate, calcium gluconate, potassium phosphate monobasic, potassium gluconate, potassium citrate, potassium fluoride, potassium chloride, potassium iodide, potassium aspartate, manganese ascorbate, manganese aspartate, manganese carbonate, manganese citrate, manganese chloride, manganese gluconate, magnesium hydroxide, magnesium citrate, magnesium ascorbate, magnesium succinate, magnesium chloride hexahydrate, magnesium sulphate heptahydrate, sodium ascorbate, sodium phosphate monobasic, sodium carbonate, sodium gluconate, sodium fluoride, sodium chloride, zinc gluconate, zinc ascorbate, zinc sulphate heptahydrate, sodium selenite, sodium selenate and s
- the controller provided with suitable software, manages the necessary doses on the basis of the set recipes, everything being controlled by dosing pumps dedicated to every salt tank.
- the salts are stored in crystalline form, further advantages are obtained compared to the case in which the salts are stored in concentrated liquid solutions.
- figure 1 schematically shows one of the possible configurations of the system for producing the liquid saline concentrate.
- the system 1 for producing a liquid saline concentrate 10 that can be diluted to obtain water intended for human consumption comprises a reverse osmosis demineraliser 2 for preparing demineralised water, a sterilisation means 3 for sterilising the demineralised water, a source 4 of CO2, a carbonator 5 for carbonating the sterilised water, a mixing tank 6 connected to the carbonator 5, a supply circuit for supplying salts to the mixing tank 6, an adjustment means 7 for adjusting the pH of the liquid saline concentrate 10 present in the mixing tank 6 in an interval comprised between 4 and 9, and a mechanical stirring means 8 for stirring the liquid saline concentrate 10 present in the mixing tank 6.
- a supply pump 16 is provided in order to supply the demineralised CCk-saturated water from the carbonator 5 to the mixing tank 6.
- the demineraliser 2 can be supplied with mains water.
- the sterilising means 3 is positioned along the water circuit supplying the mixing tank 6, and may comprise one or more UV lamps.
- a UV lamp is positioned downstream of the carbonator and upstream of a 0.2 micron filter; in the mixing tank, close to the water inlet, there is an additional UV lamp, and at the mixing tank outlet there is another 0.2 micron filter and in sequence a UV lamp.
- the salt supply circuit comprises a plurality of storage tanks 9a, 9b, 9c for storing salts in crystalline form.
- the storage tanks 9a, 9b, 9c comprise a tank for storing potassium bicarbonate salt and/or a tank for storing sodium bicarbonate salt 9a, at least one tank for storing a calcium salt 9b, and at least one tank for storing a salt other than a calcium salt 9c.
- a tank for storing potassium bicarbonate salt 9a and a tank for storing sodium bicarbonate salt 9a are provided, in other system solutions only one of them.
- the calcium salts can, for example but not necessarily, be selected from among one or more calcium salts including calcium ascorbate, calcium carbonate, calcium sulphate dihydrate, calcium citrate, calcium fluoride, calcium chloride dihydrate and calcium gluconate.
- At least one salt other than a calcium salt can for example include a magnesium salt.
- the magnesium salts can, for example but not necessarily, be selected from among one or more magnesium salts including magnesium hydroxide, magnesium citrate, magnesium ascorbate, magnesium succinate, magnesium chloride hexahydrate and magnesium sulphate heptahydrate.
- the salts other than calcium salts can include, for example but not necessarily, potassium phosphate monobasic, potassium gluconate, potassium citrate, potassium fluoride, potassium chloride, potassium iodide, potassium aspartate, manganese ascorbate, manganese aspartate, manganese carbonate, manganese citrate, manganese chloride, manganese gluconate, sodium ascorbate, sodium phosphate monobasic, sodium carbonate, sodium gluconate, sodium fluoride, sodium chloride, zinc gluconate, zinc ascorbate, zinc sulphate heptahydrate, sodium selenite, sodium selenate and selenomethionine .
- the storage tanks 9a, 9b, 9c can be connected to corresponding distributors (not shown) of weighed doses of salts in crystalline form or in liquid form.
- the salt supply circuit can comprise one or more feed pumps 14a 14b, 14c, preferably one for each salt stored in each storage tank.
- the system 1 is provided with a controller 11 configured to control the sequential feeding of the salts present in the storage tanks 9a, 9b, 9c to the mixing tank 6.
- the controller 11 is programmed to control the feeding, first or last, of the bicarbonates, the potassium bicarbonate salt or the sodium bicarbonate salt if only one of them is provided for, in any order or together if both are provided for.
- the storage tanks 9a, 9b, 9c contain crystalline salt or salt in liquid form.
- the controller 11 is programmed to draw the exact quantity from the storage tanks 9a, 9b, 9c on the basis of the individual recipes.
- the controller 11 can control the activation of the feed pumps 14a, 14b, 14c with the delays necessary for feeding the bicarbonates first or last.
- the source 4 of CO2 is connected to the bottom of the mixing tank 6 by means of a bubbler 12 for bubbling CO2 into the liquid saline concentrate present in the mixing tank 6.
- the mixing tank 6 is connected to a means for portioned packaging of the liquid saline concentrate.
- the mixing tank 6 comprises an openable lid.
- the lid can optionally have a hermetic sealing system.
- the system 1 coordinated by the controller 11 , operates in the following manner.
- the reverse osmosis demineraliser 2 obtains a first quantity of demineralised water from mains water.
- the demineralised water is first sterilised and then saturated with CO2 by the carbonator 5.
- the pump 16 is activated and the first quantity of CCk-saturated demineralised water is then introduced into the mixing tank 6 after undergoing a second sterilisation step.
- the dosing pumps 14a, 14b, 14c are activated and the soluble salts present in the storage tanks are drawn in the programmed quantities and sequence according to the recipe and introduced into the mixing tank 6.
- the mixing tank 6 is then fed by the bubbler 12 to maintain the liquid saline solution saturated with CO2, but only if the pH has not reached the required value.
- the addition first or, preferably, last of the Sodium and/or Potassium bicarbonates makes it possible to avoid the formation of local concentrations of Ca 2+ ions in a carbonate environment, which could trigger the precipitation of CaCCb.
- the process for producing the liquid concentrate makes it possible to obtain satisfactory concentrations of Calcium without the concentration of Chloride and Sulphate being too high (Chlorides and above all Sulphates impart a bitter taste to water), and to obtain adequate levels of Bicarbonate while maintaining the concentrations of Sodium and Potassium at acceptable levels.
- the liquid saline concentrate produced in the mixing tank 6 is packaged in doses, particularly in capsules or bags, to be used by special equipment directly on the site where the mineral water is produced and consumed.
- the mineral water is produced and dispensed by the equipment by diluting the liquid concentrate with demineralised sterilised water.
- the dilution ratio is comprised between 1:10 and 1:60, in particular it is equal to about 1:20 for doses in capsules and about 1: 50 for doses in bags.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The system for producing a liquid saline concentrate that can be diluted to obtain water intended for human consumption, comprises a reverse osmosis demineraliser (2) for preparing demineralised water, a sterilisation means (3) for sterilising the demineralised water, a source (4) of CO2, a carbonator (5) for carbonating the sterilised water, a mixing tank (6) connected to the carbonator (5), a supply circuit for supplying salts to the mixing tank (6), an adjustment means (7) for adjusting the pH of the liquid saline concentrate (10) present in the mixing tank (6) in an interval comprised between 4 and 9, a mechanical stirring means (8) for stirring the liquid saline concentrate (10) present in the mixing tank (6), the supply circuit comprising a plurality of storage tanks (9a,9b, 9c) for storing salts in crystalline or liquid form connected to the demineraliser (2), and per for each storage tank (9a, 9b, 9c) a corresponding dosing pump (14a, 14b, 14c), the storage tanks (9a, 9b, 9c) comprising a tank for storing potassium bicarbonate salt and/or a tank for storing sodium bicarbonate salt (9a), at least one tank for storing a calcium salt (9b), and at least one tank for storing a salt other than a calcium salt (9c), there being further provided a controller (11) for the sequential feeding of the salts present in the storage tanks (9a, 9b, 9c) to the mixing tank, the controller (11) being programmed to feed the potassium bicarbonate salt and/or the sodium bicarbonate salt first or last.
Description
PRODUCTION PLANT OF A DILUTABLE LIQUID SALINE CONCENTRATE FOR OBTAINING WATER INTENDED FOR HUMAN CONSUMPTION
DESCRIPTION
The present invention relates to a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or also one not present in nature, the liquid concentrate thus obtained and the water intended for human consumption produced with the liquid concentrate thus obtained.
From a chemical viewpoint, the preparation of water intended for human consumption obtained by remineralisation of a virtually ion-free water is a complex problem, especially when it is chosen, for reasons of convenience, to start from a liquid concentrate produced on an industrial scale and subsequently sold in doses dilutable on site according to the requirements for the production of the final product.
It should be observed first of all that the ions most commonly and widely present in natural water are essentially Calcium, Magnesium and Bicarbonate, followed by Sodium, Potassium, Chloride and Sulphate. In addition, the chemical composition of natural mineral waters suggests that the most abundant species is Calcium Bicarbonate (Calcium hydrogen carbonate).
The first problem in obtaining a liquid concentrate that can be diluted for the production of “synthetic” mineral water characterised by a reasonable calcium- carbonate balance is therefore that Calcium Bicarbonate (unlike Carbonate) does not exist in a solid state, but exclusively in an aqueous solution.
The second problem is that account must also be taken of the possible precipitation
of salts precisely in the liquid concentrate, either at the moment of preparation, or over time, as a consequence of temperature variations, exposure to UV rays, etc. In practical terms, the most critical aspect regards precisely the possible precipitation of Calcium Carbonate.
The technical task of the present invention is therefore to provide a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or one that is not present in nature, which enables the aforementioned technical drawbacks of the prior art to be eliminated.
Within the scope of this technical task, one object of the invention is to provide a system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or one that is not present in nature, wherein the liquid concentrate produced has a reasonable calcium-carbonate balance and a negligible or zero quantity of precipitated salts, particularly of Calcium Carbonate.
The technical task, as well as these and other objects, according to the present invention, are achieved by providing a system for producing a liquid saline concentrate that can be diluted to obtain water intended for human consumption, characterised in that it comprises a reverse osmosis demineraliser for preparing demineralised water, a sterilising means for sterilising said demineralised water, a source of CO2, a carbonator for carbonating said sterilised water, a mixing tank connected to said carbonator, a supply circuit for supplying salts to said mixing tank, an adjustment means for adjusting the pH of the liquid saline concentrate present in the mixing tank in an interval comprised between 4 and 9, a mechanical
stirring means for stirring the liquid saline concentrate present in the mixing tank, said supply circuit comprising a plurality of storage tanks for storing salts in crystalline form or in liquid form connected to said demineraliser, and for each storage tank a corresponding dosing pump, said storage tanks comprising a tank for storing potassium bicarbonate salt and/or a tank for storing sodium bicarbonate salt, at least one tank for storing a calcium salt, and at least one tank for storing a salt other than a calcium salt, there being further provided a controller for sequential feeding of the salts present in the storage tanks to the mixing tank, said controller being programmed to feed said potassium bicarbonate salt and/or said sodium bicarbonate salt first or last.
In general, it has been found to be convenient to use salts, in appropriate quantities based on the recipes, selected from among calcium ascorbate, calcium carbonate, calcium sulphate dihydrate, calcium citrate, calcium fluoride, calcium chloride dihydrate, calcium gluconate, potassium phosphate monobasic, potassium gluconate, potassium citrate, potassium fluoride, potassium chloride, potassium iodide, potassium aspartate, manganese ascorbate, manganese aspartate, manganese carbonate, manganese citrate, manganese chloride, manganese gluconate, magnesium hydroxide, magnesium citrate, magnesium ascorbate, magnesium succinate, magnesium chloride hexahydrate, magnesium sulphate heptahydrate, sodium ascorbate, sodium phosphate monobasic, sodium carbonate, sodium gluconate, sodium fluoride, sodium chloride, zinc gluconate, zinc ascorbate, zinc sulphate heptahydrate, sodium selenite, sodium selenate and selenomethionine .
The controller, provided with suitable software, manages the necessary doses on
the basis of the set recipes, everything being controlled by dosing pumps dedicated to every salt tank.
If the salts are stored in crystalline form, further advantages are obtained compared to the case in which the salts are stored in concentrated liquid solutions.
The times and costs of procuring crystalline salts in the required quantities are extremely reduced, as they do not require the use of specialised labour resources or the use of water resources.
Furthermore, the storage of crystalline salts does not require any particular attention, unlike liquid saline concentrates, which require constant and continuous monitoring in order to evaluate quality and presence of precipitates.
Additional features and advantages of the invention will become more apparent from the description of one embodiment of the system for preparing a liquid concentrate that can be diluted to obtain water intended for human consumption and having the characteristics of a natural mineral water or one that is not present in nature according to the invention, illustrated by way of example in the appended drawing, in which: figure 1 schematically shows one of the possible configurations of the system for producing the liquid saline concentrate.
The system 1 for producing a liquid saline concentrate 10 that can be diluted to obtain water intended for human consumption comprises a reverse osmosis demineraliser 2 for preparing demineralised water, a sterilisation means 3 for sterilising the demineralised water, a source 4 of CO2, a carbonator 5 for carbonating the sterilised water, a mixing tank 6 connected to the carbonator 5, a supply circuit for supplying salts to the mixing tank 6, an adjustment means 7 for
adjusting the pH of the liquid saline concentrate 10 present in the mixing tank 6 in an interval comprised between 4 and 9, and a mechanical stirring means 8 for stirring the liquid saline concentrate 10 present in the mixing tank 6.
A supply pump 16 is provided in order to supply the demineralised CCk-saturated water from the carbonator 5 to the mixing tank 6.
The demineraliser 2 can be supplied with mains water.
The sterilising means 3 is positioned along the water circuit supplying the mixing tank 6, and may comprise one or more UV lamps.
For example, but not necessarily, a UV lamp is positioned downstream of the carbonator and upstream of a 0.2 micron filter; in the mixing tank, close to the water inlet, there is an additional UV lamp, and at the mixing tank outlet there is another 0.2 micron filter and in sequence a UV lamp.
The salt supply circuit comprises a plurality of storage tanks 9a, 9b, 9c for storing salts in crystalline form.
The storage tanks 9a, 9b, 9c comprise a tank for storing potassium bicarbonate salt and/or a tank for storing sodium bicarbonate salt 9a, at least one tank for storing a calcium salt 9b, and at least one tank for storing a salt other than a calcium salt 9c. In some system solutions both a tank for storing potassium bicarbonate salt 9a and a tank for storing sodium bicarbonate salt 9a are provided, in other system solutions only one of them.
The calcium salts can, for example but not necessarily, be selected from among one or more calcium salts including calcium ascorbate, calcium carbonate, calcium sulphate dihydrate, calcium citrate, calcium fluoride, calcium chloride dihydrate and calcium gluconate.
At least one salt other than a calcium salt can for example include a magnesium salt.
The magnesium salts can, for example but not necessarily, be selected from among one or more magnesium salts including magnesium hydroxide, magnesium citrate, magnesium ascorbate, magnesium succinate, magnesium chloride hexahydrate and magnesium sulphate heptahydrate.
In addition to the magnesium salts, the salts other than calcium salts can include, for example but not necessarily, potassium phosphate monobasic, potassium gluconate, potassium citrate, potassium fluoride, potassium chloride, potassium iodide, potassium aspartate, manganese ascorbate, manganese aspartate, manganese carbonate, manganese citrate, manganese chloride, manganese gluconate, sodium ascorbate, sodium phosphate monobasic, sodium carbonate, sodium gluconate, sodium fluoride, sodium chloride, zinc gluconate, zinc ascorbate, zinc sulphate heptahydrate, sodium selenite, sodium selenate and selenomethionine .
The storage tanks 9a, 9b, 9c can be connected to corresponding distributors (not shown) of weighed doses of salts in crystalline form or in liquid form.
The salt supply circuit can comprise one or more feed pumps 14a 14b, 14c, preferably one for each salt stored in each storage tank.
The system 1 is provided with a controller 11 configured to control the sequential feeding of the salts present in the storage tanks 9a, 9b, 9c to the mixing tank 6.
The controller 11 is programmed to control the feeding, first or last, of the bicarbonates, the potassium bicarbonate salt or the sodium bicarbonate salt if only one of them is provided for, in any order or together if both are provided for.
The storage tanks 9a, 9b, 9c contain crystalline salt or salt in liquid form.
The controller 11 is programmed to draw the exact quantity from the storage tanks 9a, 9b, 9c on the basis of the individual recipes.
The controller 11 can control the activation of the feed pumps 14a, 14b, 14c with the delays necessary for feeding the bicarbonates first or last.
The source 4 of CO2 is connected to the bottom of the mixing tank 6 by means of a bubbler 12 for bubbling CO2 into the liquid saline concentrate present in the mixing tank 6.
The mixing tank 6 is connected to a means for portioned packaging of the liquid saline concentrate.
Finally, the mixing tank 6 comprises an openable lid.
The lid can optionally have a hermetic sealing system.
In a preferred embodiment, the system 1 , coordinated by the controller 11 , operates in the following manner.
The reverse osmosis demineraliser 2 obtains a first quantity of demineralised water from mains water.
The demineralised water is first sterilised and then saturated with CO2 by the carbonator 5.
The pump 16 is activated and the first quantity of CCk-saturated demineralised water is then introduced into the mixing tank 6 after undergoing a second sterilisation step.
At this point the dosing pumps 14a, 14b, 14c are activated and the soluble salts present in the storage tanks are drawn in the programmed quantities and sequence according to the recipe and introduced into the mixing tank 6.
The mixing tank 6 is then fed by the bubbler 12 to maintain the liquid saline solution saturated with CO2, but only if the pH has not reached the required value. The addition first or, preferably, last of the Sodium and/or Potassium bicarbonates makes it possible to avoid the formation of local concentrations of Ca2+ ions in a carbonate environment, which could trigger the precipitation of CaCCb.
The process for producing the liquid concentrate makes it possible to obtain satisfactory concentrations of Calcium without the concentration of Chloride and Sulphate being too high (Chlorides and above all Sulphates impart a bitter taste to water), and to obtain adequate levels of Bicarbonate while maintaining the concentrations of Sodium and Potassium at acceptable levels.
After further sterilisation, the liquid saline concentrate produced in the mixing tank 6 is packaged in doses, particularly in capsules or bags, to be used by special equipment directly on the site where the mineral water is produced and consumed. The mineral water is produced and dispensed by the equipment by diluting the liquid concentrate with demineralised sterilised water.
The dilution ratio is comprised between 1:10 and 1:60, in particular it is equal to about 1:20 for doses in capsules and about 1: 50 for doses in bags.
The materials used, as well as the dimensions, may in practice be any whatsoever according to needs and the state of the art.
Claims
1. A system (1) for producing a liquid saline concentrate (10) that can be diluted to obtain water intended for human consumption, characterised in that it comprises a reverse osmosis demineraliser (2) for preparing demineralised water, a sterilisation means (3) for sterilising said demineralised water, a source (4) of CO2, a carbonator (5) for carbonating said sterilised water, a mixing tank (6) connected to said carbonator (5), a supply circuit for supplying salts to said mixing tank (6), an adjustment means (7) for adjusting the pH of the liquid saline concentrate (10) present in the mixing tank (6) in an interval comprised between 4 and 9, a mechanical stirring means (8) for stirring the liquid saline concentrate (10) present in the mixing tank (6), said supply circuit comprising a plurality of storage tanks (9a, 9b, 9c) for storing salts in crystalline form or in liquid form connected to said demineraliser (2) and for each storage tank (9a, 9b, 9c) a respective dosing pump (14a, 14b, 14c), said storage tanks (9a, 9b, 9c) comprising a tank for storing potassium bicarbonate salt and/or a tank for storing sodium bicarbonate salt (9a), at least one tank for storing a calcium salt (9b), and at least one tank for storing a salt other than a calcium salt (9c), there being further provided a controller (11) for the sequential feeding of the salts present in the storage tanks (9a, 9b, 9c) to the mixing tank (6), said controller (11) being programmed to feed said potassium bicarbonate salt and/or said sodium bicarbonate salt first or last.
2. The system (1) for producing a dilutable liquid saline concentrate according to the preceding claim, characterised in that it comprises one or more storage
tanks for storing calcium salts selectable from one or more of the following salts: calcium ascorbate, calcium carbonate, calcium sulphate dihydrate, calcium citrate, calcium fluoride, calcium chloride dihydrate and calcium gluconate. The system (1) for producing a dilutable liquid saline concentrate according to any preceding claim, characterised in that it comprises one or more storage tanks for storing magnesium salts selectable from one or more of the following salts: magnesium hydroxide, magnesium citrate, magnesium ascorbate, magnesium succinate, magnesium chloride hexahydrate and magnesium sulphate heptahydrate. The system (1) for producing a dilutable liquid saline concentrate according to any preceding claim, characterised in that it comprises one or more storage tanks for storing salts other than calcium salts selectable from one or more of the following salts: potassium phosphate monobasic, potassium gluconate, potassium citrate, potassium fluoride, potassium chloride, potassium iodide, potassium aspartate, manganese ascorbate, manganese aspartate, manganese carbonate, manganese citrate, manganese chloride, manganese gluconate, sodium ascorbate, sodium phosphate monobasic, sodium carbonate, sodium gluconate, sodium fluoride, sodium chloride, zinc gluconate, zinc ascorbate, zinc sulphate heptahydrate, sodium selenite, sodium selenate and selenomethionine. The system (1) for producing a dilutable liquid saline concentrate according to any preceding claim, characterised in that said source (4) of CO2 is connected to the bottom of said mixing tank (6) by means of a bubbler 12
for bubbling CO2 into the liquid saline concentrate present in the mixing tank (6).
6. The system (1) for producing a dilutable liquid saline concentrate according to any preceding claim, characterised in that said mixing tank (6) is connected to a means for portioned packaging of said liquid saline concentrate.
7. The system (1) for producing a dilutable liquid saline concentrate according to any preceding claim, characterised in that said mixing tank (6) comprises an openable closure lid.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202190000357.3U CN219460262U (en) | 2020-03-18 | 2021-03-18 | System for producing liquid brine concentrate |
EP21723919.3A EP4106549A1 (en) | 2020-03-18 | 2021-03-18 | Production plant of a dilutable liquid saline concentrate for obtaining water intended for human consumption |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT202020000001216U IT202000001216U1 (en) | 2020-03-18 | 2020-03-18 | PLANT FOR THE PRODUCTION OF A DILUTABLE LIQUID SALINE CONCENTRATE FOR OBTAINING WATER INTENDED FOR HUMAN CONSUMPTION |
IT202020000001216 | 2020-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021186482A1 true WO2021186482A1 (en) | 2021-09-23 |
Family
ID=75825818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT2021/000013 WO2021186482A1 (en) | 2020-03-18 | 2021-03-18 | Production plant of a dilutable liquid saline concentrate for obtaining water intended for human consumption |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4106549A1 (en) |
CN (1) | CN219460262U (en) |
IT (1) | IT202000001216U1 (en) |
WO (1) | WO2021186482A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004103097A2 (en) * | 2003-05-23 | 2004-12-02 | Sara Lee/De N.V. | Mineral concentrate |
EP2582635A1 (en) * | 2010-06-16 | 2013-04-24 | Berger, Simona | Process and plant for the preparation of a dilutable liquid concentrate to obtain water destined for human consumption and having the characteristics of a natural mineral water, liquid concentrate and water destined for human consumption thus obtained |
US20170000164A1 (en) * | 2013-12-18 | 2017-01-05 | Nestec S.A. | Process for supplying magnesium and/or calcium enriched water based beverage and associated manufacturing apparatus |
-
2020
- 2020-03-18 IT IT202020000001216U patent/IT202000001216U1/en unknown
-
2021
- 2021-03-18 WO PCT/IT2021/000013 patent/WO2021186482A1/en active Application Filing
- 2021-03-18 CN CN202190000357.3U patent/CN219460262U/en active Active
- 2021-03-18 EP EP21723919.3A patent/EP4106549A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004103097A2 (en) * | 2003-05-23 | 2004-12-02 | Sara Lee/De N.V. | Mineral concentrate |
EP2582635A1 (en) * | 2010-06-16 | 2013-04-24 | Berger, Simona | Process and plant for the preparation of a dilutable liquid concentrate to obtain water destined for human consumption and having the characteristics of a natural mineral water, liquid concentrate and water destined for human consumption thus obtained |
US20170000164A1 (en) * | 2013-12-18 | 2017-01-05 | Nestec S.A. | Process for supplying magnesium and/or calcium enriched water based beverage and associated manufacturing apparatus |
Also Published As
Publication number | Publication date |
---|---|
EP4106549A1 (en) | 2022-12-28 |
IT202000001216U1 (en) | 2021-09-18 |
CN219460262U (en) | 2023-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3181521A1 (en) | Purified and re-mineralized water | |
US20050152811A1 (en) | Apparatus and methods for efficient generation of chlorine dioxide | |
EP1365663B1 (en) | Process, apparatus and composition for calcium fortification of beverages | |
TWI423921B (en) | Preparation method of hypochlorite solution like molecule by ionic exchange and hypochlorite solution like molecule | |
EP3091862A1 (en) | Process for supplying magnesium and/or calcium enriched water based beverage and associated manufacturing apparatus | |
CA2377076C (en) | Preparation and metering of components mixed with co2 | |
US6602442B1 (en) | Composition for generating chlorine dioxide | |
US8277848B2 (en) | Method for preparing aqueous solution of high-concentration calcium phosphate stable in neutral pH range | |
WO2021186482A1 (en) | Production plant of a dilutable liquid saline concentrate for obtaining water intended for human consumption | |
EP2582635B1 (en) | Process for the preparation of a dilutable liquid concentrate to obtain water destined for human consumption and having the characteristics of a natural mineral water | |
WO2004103097A2 (en) | Mineral concentrate | |
US20040028792A1 (en) | Method for producing water rich in calcium and water obtained | |
US20140332399A1 (en) | Low Capacity Sodium Hypochlorite Generation System | |
US20190045823A1 (en) | A process for making a liquid low sodium food-grade salt | |
US11638439B2 (en) | Vitamin D-fortified water and method of manufacturing thereof | |
RU2568846C2 (en) | Acid dialysis concentrate | |
JP7541636B2 (en) | How to make hypochlorous acid water | |
KR20200004203A (en) | A composition for providing room temperature long-term constant-concentration chlorine dioxide solution in aqueous medium and preparation method thereof | |
US20230406703A1 (en) | Hypochlorite water production method and production apparatus | |
WO2012053942A1 (en) | Solutions for bicarbonate hemodialysis | |
CN101538017B (en) | Process for producing high-purity chlorine dioxide | |
CN117303681A (en) | Seawater desalination water quality adjusting and storing device and adjusting process thereof | |
WO2021257377A1 (en) | System and method for making hypochlorous acid using saltwater with sodium bicarbonate | |
JP2014043392A (en) | Weakly acidic hypochlorous acid, and production device and production method therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21723919 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202190000357.3 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2021723919 Country of ref document: EP Effective date: 20220919 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |